➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Mallinckrodt
McKesson
Baxter
Dow

Last Updated: June 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Onapristone


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Onapristone?

Onapristone is an investigational drug.

There have been 9 clinical trials for Onapristone. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2021.

The most common disease conditions in clinical trials are Breast Neoplasms, Endometrial Neoplasms, and Ovarian Neoplasms. The leading clinical trial sponsors are Context Therapeutics, Arno Therapeutics, and Memorial Sloan Kettering Cancer Center.

Recent Clinical Trials for Onapristone
TitleSponsorPhase
A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast CancerContext TherapeuticsPhase 1
A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast CancerMemorial Sloan Kettering Cancer CenterPhase 1
Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)University of Wisconsin, MadisonPhase 2

See all Onapristone clinical trials

Clinical Trial Summary for Onapristone

Top disease conditions for Onapristone
Top clinical trial sponsors for Onapristone

See all Onapristone clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Harvard Business School
McKinsey
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.